Integrating clinical research with the Healthcare Enterprise: From the RE-USE project to the EHR4CR platform  by El Fadly, AbdenNaji et al.
Journal of Biomedical Informatics 44 (2011) S94–S102Contents lists available at SciVerse ScienceDirect
Journal of Biomedical Informatics
journal homepage: www.elsevier .com/locate /y jb inIntegrating clinical research with the Healthcare Enterprise: From the RE-USE
project to the EHR4CR platformq
AbdenNaji El Fadly a, Bastien Rance b,1, Noël Lucas b, Charles Mead c, Gilles Chatellier b,d,f,
Pierre-Yves Lastic e, Marie-Christine Jaulent a, Christel Daniel a,d,f,⇑
a INSERM, UMR_S 872 eq20, 15 rue de l’école de médecine, 75006 Paris, France
bAP-HP, Clinical Research Unit, Georges Pompidou Hospital, 20 rue Leblanc, 75015 Paris, France
cNational Cancer Institute, 3rd Millennium Consulting, Center for Biomedical Informatics and Information Technology, 2115 East Jefferson St., 6th Floor, Rockville, MD 20852, USA
d Paris Descartes University, 75006 Paris, France
eCDISC Board of Directors and Sanoﬁ-Aventis R&D, 1 avenue Pierre Brossolette, 91385 Chilly-Mazarin Cedex, France
fAP-HP, Medical Informatics Department, Georges Pompidou Hospital, 20 rue Leblanc, 75015 Paris, Francea r t i c l e i n f o
Article history:
Received 1 March 2011
Accepted 22 July 2011
Available online 25 August 2011
Keywords:
Translational research
Clinical protocols
Information systems
Terminology
Controlled vocabulary
Semantic interoperability
CDISE
HL7
IHE1532-0464  2011 Elsevier Inc.
doi:10.1016/j.jbi.2011.07.007
q The authors have no relevant ﬁnancial interest in
⇑ Corresponding author at: INSERM, UMR_S 872 eq
E-mail addresses: nelfadly@yahoo.fr (A. El Fad
gilles.chatellier@egp.aphp.fr (G. Chatellier), pierre-y
crc.jussieu.fr (C. Daniel).
1 Present address: US National Institutes of Health, U
Open access under CC BYa b s t r a c t
Background: There are different approaches for repurposing clinical data collected in the Electronic
Healthcare Record (EHR) for use in clinical research. Semantic integration of ‘‘siloed’’ applications across
domain boundaries is the raison d’être of the standards-based proﬁles developed by the Integrating the
Healthcare Enterprise (IHE) initiative – an initiative by healthcare professionals and industry promoting
the coordinated use of established standards such as DICOM and HL7 to address speciﬁc clinical needs in
support of optimal patient care. In particular, the combination of two IHE proﬁles – the integration proﬁle
‘‘Retrieve Form for Data Capture’’ (RFD), and the IHE content proﬁle ‘‘Clinical Research Document’’ (CRD)
– offers a straightforward approach to repurposing EHR data by enabling the pre-population of the case
report forms (eCRF) used for clinical research data capture by Clinical Data Management Systems (CDMS)
with previously collected EHR data.
Objective: Implement an alternative solution of the RFD–CRD integration proﬁle centered around two
approaches: (i) Use of the EHR as the single-source data-entry and persistence point in order to ensure
that all the clinical data for a given patient could be found in a single source irrespective of the data col-
lection context, i.e. patient care or clinical research; and (ii) Maximize the automatic pre-population pro-
cess through the use of a semantic interoperability services that identify duplicate or semantically-
equivalent eCRF/EHR data elements as they were collected in the EHR context.
Methods: The RE-USE architecture and associated proﬁles are focused on deﬁning a set of scalable, stan-
dards-based, IHE-compliant proﬁles that can enable single-source data collection/entry and cross-system
data reuse through semantic integration. Speciﬁcally, data reuse is realized through the semantic map-
ping of data collection ﬁelds in electronic Case Report Forms (eCRFs) to data elements previously deﬁned
as part of patient care-centric templates in the EHR context. The approach was evaluated in the context of
a multi-center clinical trial conducted in a large, multi-disciplinary hospital with an installed EHR.
Results: Data elements of seven eCRFs used in a multi-center clinical trial were mapped to data elements
of patient care-centric templates in use in the EHR at the George Pompidou hospital. 13.4% of the data
elements of the eCRFs were found to be represented in EHR templates and were therefore candidate
for pre-population. During the execution phase of the clinical study, the semantic mapping architecture
enabled data persisted in the EHR context as part of clinical care to be used to pre-populate eCRFS for use
without secondary data entry. To ensure that the pre-populated data is viable for use in the clinical
research context, all pre-populated eCRF data needs to be ﬁrst approved by a trial investigator prior to
being persisted in a research data store within a CDMS.
Conclusion: Single-source data entry in the clinical care context for use in the clinical research context – a
process enabled through the use of the EHR as single point of data entry, can – if demonstrated to be a
viable strategy – not only signiﬁcantly reduce data collection efforts while simultaneously increasingthe products or companies described in this article.
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A. El Fadly et al. / Journal of Biomedical Informatics 44 (2011) S94–S102 S95data collection accuracy secondary to elimination of transcription or double-entry errors between the
two contexts but also ensure that all the clinical data for a given patient, irrespective of the data collec-
tion context, are available in the EHR for decision support and treatment planning.
Conclusion: The RE-USE approach used mapping algorithms to identify semantic coherence between
clinical care and clinical research data elements and pre-populate eCRFs. The RE-USE project utilized
SNOMED International v.3.5 as its ‘‘pivot reference terminology’’ to support EHR-to-eCRF mapping, a
decision that likely enhanced the ‘‘recall’’ of the mapping algorithms. The RE-USE results demonstrate
the difﬁcult challenges involved in semantic integration between the clinical care and clinical research
contexts.
 2011 Elsevier Inc. Open access under CC BY-NC-ND license. 1. Introduction
Despite the fact that patients involved in clinical trials are often
undergoing simultaneous clinical care for conditions that overlap
with the scope of the clinical trial in which they are enrolled, the
data collection, processing requirements, and information systems
that collectively deﬁne the two contexts of clinical care and clinical
research have historically been essentially disjoint. However, over
the past decade, the increasingly widespread adoption of Elec-
tronic Health Record (EHR) systems as a standard part of the clin-
ical care context has made the goal of re-purposing data collected
during the course of clinical care for use in the clinical research
context a more feasible and tractable possibility. Recently, a num-
ber of investigators have examined the various roles that EHR sys-
tems might assume in the clinical research context [1–6]. Some
[7,8] have pointed out that EHR data may be useful during trial de-
sign by providing trial planners with a better understanding of the
available cohorts based on the trial’s Inclusion and Exclusion crite-
ria, while others [9–12] have speciﬁcally discussed the lessening
and optimization of the clinical trial data collection burden
through the targeted re-purposing of EHR data during a trial’s exe-
cution phase. This latter perspective is particularly focused on inef-
ﬁciency and potential inaccuracy of ‘‘double data entry,’’ i.e. the
collection of the same data in both the clinical care and clinical re-
search contexts. Various studies have estimated that between 30%
and 50% of data are redundantly captured for patients simulta-
neously enrolled in one or more studies while receiving ongoing
clinical care [13,14].
In the clinical care context, data are routinely collected for per-
sistence and processing by each healthcare facility’s EHR system. In
the clinical research context, the pharmaceutical industry has his-
torically invested heavily in tools and technologies to improve the
efﬁciency, accuracy, and speed of electronic data collection by
replacing paper-based Case Report Forms (CRFs) with so-called
electronic data capture (EDC) of electronic CRFs (eCRFs). Currently,
eCRFs are used to capture trial-speciﬁc data in a number of settings
including trial subjects’ homes and participating physicians’ ofﬁ-
ces. It has been reported that EDC is now the preferred method
of data capture for clinical trials, and that EDC technologies are
now used as the primary data collection tool in 58% of global clin-
ical trials [14]. Once collected, data are persisted and processed by
a number of vendor- and/or in-house-developed Clinical Data
Management Systems (CDMS). Given that both the clinical care
and the clinical research context now have robust and reliable
electronic data collection capabilities, re-purposing clinical data
captured in EHRs would appear to make sound operational sense.
In particular, several groups have formulated user requirements,
use cases, and technical frameworks for EHR–CDMS integration
including CDISC eSDI, eClinical Forum/PhRMA EDC/eSource Task-
force, EHR/CR-project [15–17].
There are several possible approaches that could be taken to
achieve the goal of ‘‘single-data-entry’’ operationalizing of EHR/
CDMS data integration. In particular, the Clinical Data InterchangeStandards Consortium (CDISC) has deﬁned three approaches to
EHR/CDMS data integration [15]:
(i) Single-Source Concept: Data are entered into an electronic
source document at the site. All of the data can ﬂow into
the EHR database, while a presumed subset of the data as
identiﬁed by a speciﬁc trial’s protocol are simultaneously
passed into an ‘‘eSource repository’’ and then onwards to
the CDMS/clinical trial database.
(ii) Extraction and Investigator Veriﬁcation: The single-source
data collection strategy (above) is enhanced with the addi-
tional step of requiring that one of the trial’s designated
investigator verify that the extracted data, for clinical
research use, accurately reﬂect the source data for that sub-
ject before it is included as part of the clinical trial data
record, a step which ensures compliance with trial data
integrity and quality regulations. Speciﬁc data collection
templates are often drawn from the CDMS’s forms library
for use in the clinical care context (Fig. 1).
(iii) Direct Extraction from Electronic Health Records: Data is
extracted from EHR systems with the pre-requisite require-
ment that the EHR application be pre-certiﬁed to meet the
Food and Drug Administration’s (FDA) predicate rules gov-
erning good clinical practice and human subject protection
relevant to eSource including 21 CFR Part 11.
This paper describes the Retrieve from EHR Useful clinical data
for Secondary Exploitation (RE-USE) project proposing a new
implementation of the ‘‘Extraction and Investigator Veriﬁcation’’
scenario.2. Background
2.1. Standards-based integration proﬁles: crossing the barrier between
clinical care and clinical research
Historically, a major barrier to EHR/CDMS integration has been
the fact that the standards for collecting, archiving, and transmit-
ting health data have been deﬁned by different ‘‘siloed’’ organiza-
tions in the clinical care and clinical research domains. For
example, in the domain of clinical research, the CDISC organiza-
tion has developed a number of platform-independent standards
that support the electronic acquisition, exchange, regulatory sub-
mission, and subsequent archiving of clinical research data. In
particular, in 2001, CDISC published the ﬁrst version of its Opera-
tional Data Model (ODM), a speciﬁcation that deﬁned the organi-
zation structure and syntax of data captured for analysis and
reporting over the course of a clinical trial [18]. Notably, however,
the ODM speciﬁcation did not – and still does not – specify termi-
nologies or other standards-based structures (e.g. complex data
types) that ultimately must be deﬁned to semantically specify
the data transported via an ODM instance. As such, ODM supports
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erability since each clinical trial may use ODM to transfer trial-
speciﬁc semantics within ODM’s syntactic structures. Recently,
the Clinical Data Acquisition Standards Harmonization (CDASH)
initiative speciﬁed the unambiguous semantics of a number of
common data elements that are deemed ‘‘common’’ to all trials.
As such, CDASH represents a signiﬁcant ﬁrst-step in achieving
cross-trial semantic interoperability.
In the domain of clinical care, several large-scale efforts have
been underway for over a decade with the goal of specifying both
the syntax and the semantics of patient clinical information in a
manner that enables computable semantic interoperability be-
tween diverse systems. Speciﬁcally, in the European Union, the
CEN TC 251 effort has been the most important, whereas in the
US, Canada, Australia, and Asia, HL7’s efforts have born consider-
able fruit. In 2004, CDISC and HL7 – along with the National Cancer
Institute and the FDA – began collaboration on the development of
a domain analysis model which deﬁned the static/informational
semantics of ‘‘the domain of protocol-driven research involving
human, animal, or device subjects as well as all relevant, associated
regulatory and post-marketing data’’. The effort has produced the
BRIDG (Biomedical Research Integrated Domain Group) model
which, on one side, contains representations of clinical research
data with underlying mappings to the HL7 RIM and, on the other
side, covers a superset of the scope deﬁned by CDASH [19]. The
most recent version of the BRIDG model also contains – in addition
to it original UML representation – a semantically equivalent rep-
resentation using the Web Ontology Language (OWL) and formal
binding to the HL7 Abstract Data Types Release 2. CDISC has com-
mitted to migrating all of its standards to be expressed using
BRIDG semantics, and the HL7 Regulated Clinical Research Infor-
mation Management (RCRIM) Work Group within HL7 is commit-
ted to developing all of its message speciﬁcations in the context of
BRIDG compliance. Finally, two recent efforts have focused on
bringing the various international efforts into closer alignment.
In 2003 the HL7 Reference Information Model (RIM) became an
ISO standard. In 2007, the Joint Initiative Council was formed as
a partnership between HL7, CDISC, ISO TC 215, IHTSDO, and CEN
TC 251 with the stated goal of increasing collaboration between
standards organizations based on the recognition of a common
goal of computable semantic interoperability. In 2011, ISO deﬁned
a set of data type deﬁnitions for representing and exchanging basic
concepts that are commonly encountered in healthcare environ-
ments in support of information exchange in the healthcare envi-
ronment (ISO 21090 data types). Finally, from the perspective of
data collection in both the clinical care and clinical research con-
texts – contexts which are, to a large extent, document-centric in
the organization of their data collection activities – the Clinical
Document Architecture (CDA) speciﬁcation developed by HL7
promises to play an important role going forward.
The collective efforts of the multiple organizations currently fo-
cused on deﬁning the various standards required to achieve the
overarching goal of integrated, computable semantic interoperabil-
ity certainly represents a critically important ‘‘piece of the puzzle’’
that enables single-point-of-entry EHR/CDMS integration. How-
ever, given the reality that achieving broad-based, scalable com-
putable semantic interoperability across multiple domains will
require the integration of multiple standards, it became apparent
that an ‘‘integration organization’’ involving multiple stakeholders
(including both vendor and provider organizations) could serve a
valuable role by deﬁning – based on stakeholder dialogue –
‘‘real-world usage scenarios’’ – that, in turn, could then be instan-
tiated using existing standards. The organization ‘‘Integrating the
Healthcare Enterprise’’ (IHE – http://www.ihe.net) has, in fact,
emerged as that organization. The ‘‘real-world usage scenarios’’
that are published by IHE are, in turn, referred to as IntegrationProﬁles, each proﬁle deﬁning a series of ‘‘transactions’’ which spec-
ify how existing standards should be applied to meet the overarch-
ing business goal described by the proﬁle.
Unlike, preliminary pilot studies of EHR/CDMS integration that
were one-time-only solutions limited to a single vendor, single
pharmaceutical company context, and not using standards for data
representation, two integration proﬁles dedicated to ‘‘research and
public health – as proposed by both the IHE Quality Research and
Public Health (QRPH) and Information Technology Infrastructure
(ITT) domains – address the issue of multi-vendor, scalable inter-
operability required for multicenter trials [20,21].
Speciﬁcally, the ‘‘Retrieve Form for Data-capture’’ (RFD) integra-
tion proﬁle [20] combined with the ‘‘Clinical Research Document’’
(CRD) content proﬁle [21] collectively provide a conceptual frame-
work for implementing the ‘‘single-point-of-data-collection’’ ap-
proach to EHR/CDMS integration. Fig. 1 depicts the information
ﬂow in the RFD integration proﬁle from the perspective of the clin-
ical research context. Speciﬁcally, the case report form (eCRF) is
centrally implemented in the CDM system of the clinical research
organization acting as a ‘‘Form Manager’’. The EHR system, acting
as ‘‘Form Filler,’’ retrieves the eCRF. Source data are entered in this
interface to the CDM displayed in the EHR. Clinical trial data are
stored in the CDMS acting as ‘‘Form Receiver’’. Alternatively, the
‘‘Clinical Research Document’’ (CRD) content proﬁle describes
how EHRs (regardless of the underlying EHR semantics) can
through generation of a Continuity of Care Document (CCD) pro-
vide clinical data for pre-populating eCRFS in the scope of CDISC
CDASH standard, i.e. a minimal core dataset that is valid across
all regulated clinical trials.
2.2. Semantic interoperability services
In spite of the work of – and including a number of joint initia-
tives between – several Standards Development Organizations a
number of challenges must still be addressed before scalable
semantic interoperability between EHR and CDMS can be consid-
ered a broader reality. The main issue is that information models
of EHRs and CDMSs (‘‘Models of Use’’) are almost always system-
speciﬁc. A Model of Use – whether formally or informally deﬁned
– is expressed at the user interface via the use of a so-called
‘‘Interface Terminology,’’ a concept deﬁned by Rosenbloom as
‘‘systemic collections of clinically-oriented phrases (‘‘terms’’)
aggregated to support clinicians’ data entry of patient information
directly into computer programs such as clinical documentation
systems’’ [22].
The challenge of EHR/CDMS integration relies on the capability
of mapping their respective data structures and semantics between
the two data usage contexts. One possible approach consists in
mapping data structures already deﬁned and standardized respec-
tively in patient care and clinical research. This approach is, in fact,
the rationale of the IHE content proﬁle (CRD) based on the map-
ping between CDISC CDASH data elements and Continuity of Care
Document (CCD), as well of the more broadly scoped CDISC SHARE
project planned for 2011. In particular, CDISC SHARE is based on
the BRIDG model and its underlying mapping to the HL7 RIM
and therefore relies on a single ‘‘Model of Meaning’’ providing
canonical semantics between multiple Models of Use [23]. The
concept of a Model of Meaning, described by Rector [24] and Ben-
son [25], provides a system-and-interface-terminology-indepen-
dent view of a given semantic space. The main function of a
Model of Meaning is therefore to serve as a standardized source
of meaning.
An ambitious approach consists in identifying – for each in-
stance of an EHR/CDMS integration context – the semantic overlap
between eCRFs and EHR beyond the minimum care data elements
that are applicable to all clinical trials regardless of therapeutic
Fig. 1. ‘‘Retrieve Form for Data Capture’’ (RFD). The case report form (eCRF) is centrally implemented in the Clinical Data Management System (CDMS) of the clinical research
organization acting as a ‘‘Form Manager’’. The EHR acting as ‘‘Form Filler’’ retrieves the eCRF. Source data are entered in this interface to the CDMS displayed in the EHR.
Clinical trial data are stored in the CDMS acting as ‘‘Form Receiver’’.
Fig. 2a. Overarching activity diagram of the clinical research activities of institutional sponsorship in a university hospital.
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the current trend of existing clinical applications using legacy
interface terminology that migrate this interface terminologies to
reference terminologies such as SNOMED [26–28], it is reasonable
to consider that reference terminologies used as pivot terminolo-
gies may enhance the mapping between data elements of eCRFs
and data elements already deﬁned in EHRs.
In this context, the objective of the RE-USE project is to enhance
the RFD-CRD approach for EHR/CDMS integration with a twofold
rationale. The ﬁrst expected beneﬁt of the RE-USE approach is to
store in the EHR all the clinical data of the patient whatever the
data entry context is (patient care or clinical research). Second,
the aim is to maximize the automatic pre-population process by
the use of mapping algorithms in order to identify on the ﬂy the
semantic overlap between electronic Case Report Forms (eCRFs)
and the EHR.
Following is description of the methods used to deﬁne business
models of clinical research in a university hospital environmentfocusing on the use of EHRs in this process; as well as the methods
to design and to implement the RE-USE architecture. We also pro-
vide results of the ﬁrst implementation of the RE-USE architecture
in the context of a multi-centric clinical trial, as well as comments
on next steps based on our experience in the RE-USE project.3. Methods
3.1. Settings
The Assistance Publique-Hôpitaux de Paris (AP-HP) is a large
French University Hospital System consisting of 38 hospitals in
Paris and suburbs. It has 23,000 acute-care and 1400 1-day-care
beds and handles 1100,000 hospitalizations per year. AP-HP is
the ﬁrst clinical care environment in Europe to support an inte-
grated, active clinical research context, a collection of ten Clinical
Research Units (CRUs) at the various AP-HP member hospitals –
Fig. 2b. Example of an activity diagram comprising an activity that may be supported by the EHR: ‘‘Create a clinical trial database’’. Each activity supported by the EHR is
described by a sequence diagram specifying the actors’ interactions using EHR within the RE-USE solution.
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35,000 enrolled patients. From an information technology perspec-
tive, the Clinical Research Unit (CRU) at the AP-HP member hospi-
tal George Pompidou European Hospital (HEGP) is currently
evaluating the Clinical Data Management Systems (CDMS) Mar-
vin (XClinical). In contrast, the clinical care units of HEGP have
been using a commercial EHR system – DxCare from Medasys –
since 2000. As part of the information model of DxCare, a library
of 8587 data elements distributed across 861 templates supports
structured data entry in an EHR. The interface terminology of the
EHR – referred as ‘‘PatientCare-IT’’ – consists of terms or phrases
constructed/derived from these data elements [28]. There is an
on-going process of mapping PatientCare-IT to SNOMED 3.5
(French version).3.2. Business analysis
Using the high-level use cases and activity diagrams that collec-
tively deﬁne the process framework of the BRIDG model as a start-
ing point for dialogue and analysis, we reviewed clinical research
data collection and associated relevant business processes with
the staffs of both the CRU at HEGP and the Clinical Research and
Development Department overseeing and coordinating the activi-
ties of the ten AP-HP CRUs. Of particular interest in these discus-
sions was the identiﬁcation of speciﬁc contextual details
regarding academic clinical trial sponsorship in France, with a fo-
cus on how various data collection processes could be simpliﬁed
through the use of EHRs as a ‘‘single-source’’ of data collection
and entry. Our analysis activities also considered the CRU CDMS
speciﬁcations as deﬁned by FDA guidelines published by the Cali-
fornia State University Channel Islands (CSUI), as well as recent re-
ports by HL7 (ANSI/EHR Clinical Research Functional Proﬁle) and
CEN TC 251 which deﬁne the requirements for EHR systems func-
tioning in a clinical research context.3.3. RE-USE design and implementation
Using the results of our business analysis activities, we then be-
gan our design and implementation activities. The RE-USE archi-
tecture consists in three components:(i) An implementation of an integration proﬁle that enables the
sharing/exchange of data collection templates between the
clinical care and clinical research contexts.
(ii) A component that implements a synchronization process
that maps data elements of eCRFs to data elements already
deﬁned in EHR as part of patient care-centric templates.
(NOTE: the synchronization process ensures that eCRFs are
consistently integrated to EHR data collection forms.) The
synchronization process utilizes a semantic interoperability
framework based on conceptual structures represented
using ISO 21090 data types in combination with associated
terminology mapping services which enable automatic map-
ping between the interface terminologies (ITs) which are
implemented by the EHR and CDMS respectively. An IT
includes the terms or phrases representing the data ele-
ments (‘‘questions’’) as well as the content of the value sets
(‘‘answers’’). The mapping services are not currently
addressing the scope of the value sets. Of particular interest
in the binding exercise is the use of an automatic mapping
algorithm based on a weighted combination of similarity
measures as expressed by the Levenshtein distance metric
[29].
(iii) An integration proﬁle that enables the sharing/exchange of
clinical research data between the EHR and CDMS.
With these components in place, clinicians were trained to per-
form and validate the mapping of data elements of eCRFs to data
elements in EHR. Accuracy was calculated as the ratio of true pos-
itives (correct mappings/representations) to false positives (incor-
rect mappings/representations) as performed by the clinicians and
validated by one of the authors. Precision was calculated as the ra-
tio of true positives to the sum of true positives plus false positives.
Recall was calculated as the ratio of true positives to the sum of
true positives plus false negatives. We evaluated the role of
SNOMED 3.5 as pivot terminology in order to enhance the recall
of the mapping services.3.4. RE-USE Evaluation at HEGP
The target clinical research study for our RE-USE evaluation – a
study focused on treatment modalities for hypertension caused by
ﬁbromuscular dysplasia – is referred as ‘‘Arcadia’’. Following
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study by the HEGP Institutional Review Board (IRB) – an approval
required by French law – the eCRFS, in CDISC ODM syntax, were re-
trieved for integration in DxCare. The interface terminology of the
eCRFS, i.e. the labels of the 232 data elements distributed across
the Arcadia eCRFs, was analyzed for data elements present in
EHR templates, thereby enabling the creation of the Arcadia-IT-
to-PatientCare-IT mapping. The EHR templates containing the
eCRFS data elements were then integrated into DxCare using
DxSync. During the execution phase of the Arcadia study, ‘‘DxSync’’
performed real-time data extraction and translation so that data
could then be represented in an eCRF-compliant form using the
CDISC ODM syntax. Finally, an IHE integration proﬁle was used
to operationalize the transfer via ODM ﬁles of the data collected
in the clinical care context into the clinical research context.4. Results
4.1. Business model for EHR as single source data capture solution
We modeled the clinical research activities of institutional
sponsorship in a university hospital and speciﬁed the functional
perimeter of the EHR within this context. The activity diagrams
made it possible to better identify the role of the main actors at
the time of each activity of the clinical trial implementation pro-
cess. The RE-USE business process diagram comprises 15 activity
diagrams. Each activity supported by the EHR is described by a se-
quence diagram specifying the actors’ interactions using EHR with-
in the RE-USE solution (Figs. 2a and 2b).
4.2. RE-USE architecture
4.2.1. Retrieve template for data capture
We deﬁned an integration proﬁle – referred to as ‘‘Cross Enter-
prise Tempalte Sharing’’ (XTS) based on the existing IHE ‘‘Cross
enterprise Document Media interchange’’ (XDM) integrationFig. 3. Integration proﬁles implemented in the ‘‘RE-USE approach’’. Templates of eCRFs
implemented in EHRs using the ‘‘Cross Enterprise Template Sharing’’ (XTS) integration pr
proﬁles (XDM, XDS). All data collected in the clinical care context are validated by a triproﬁle [30] allowing an EHR to retrieve the template of a form to
be integrated for data capture. The XTS integration proﬁle allows
the CDMS, acting as ‘‘Template Source’’ to distribute templates of
eCRFs to EHRs, acting as ‘‘Template Consumers’’ using the transac-
tion ‘‘Distribute Template’’. This transaction is based on the trans-
action ‘‘Distribute Document Set on Media’’ of the IHE XDM
integration proﬁle. The media is USB stick, CD-R or ZIP ﬁle sent
via a secure email message. eCRFs templates were available in a
CDISC ODM standard (Fig. 3).4.2.2. Synchronization process
When the EHR (‘‘Template Consumer’’) receives an eCRF tem-
plate (in CDISC ODM format), the speciﬁc synchronization process
‘‘DxSync’’ relies on the semantic interoperability framework to
integrate the ODM ﬁle of the eCRF in the EHR.
During the integration of an eCRF template in the EHR, DxSync
takes into account the validated mapping between ClinicalTrial-IT
and PatientCare-IT to enable the binding of each data element to
the data elements already existing in the library of the EHR. Only
new data element speciﬁc to the Clinical Research context are
added to the library. Once the eCRFs templates have been inte-
grated in DxCare, patient-speciﬁc data collection can begin. In par-
ticular, for a given instance of data collection, population of
appropriate eCRF ﬁelds by pre-existing clinical data is executed
by a custom-developed synchronization component of DxCare.4.2.3. Cross enterprise document sharing/media (XDS, XDM)
During clinical trial execution, the existing IHE ‘‘Cross enter-
prise Document Media interchange’’ (XDM) or ‘‘Cross enterprise
Document Sharing’’ (XDS) integration proﬁles allow the EHR, act-
ing as a ‘‘Document Source’’ to exchange/share eCRFs instances
(in CDISC ODM format) with the CDMS, acting as a ‘‘Document
Consumer’’.are distributed by the clinical research organization to healthcare facilities to be
oﬁle. Clinical trial data are exchanged/shared using IHE Cross Enterprise integration
al investigator before being persisted in the clinical research infrastructure.
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The RE-USE architecture was used to instantiate an instance of
EHR/CDMS integration during the execution phase of the Arcadia
trial.
4.3.1. Integrating eCRFs in EHR
The XTS integration proﬁle was used to retrieve the ODM tem-
plates corresponding to the seven eCRF of the Arcadia trial (inclu-
sion, initial evaluation, initial abdominal imaging, initial
neurovascular imaging, biological tests, adverse events, and seri-
ous adverse events) (Fig. 3).
The automatic mapping found an exact match between 15.7% of
the data elements of the Aracadia ODM templates (‘‘Arcadia-IT’’,
n = 232) and PatientCare-IT. After expert validation the Arcadia-
IT-to-PatientCare-IT mapping was of 13.4%. The precision and
recall of the algorithm were respectively of 70% and 84%. The auto-
matic mapping between the template interface terminologies
(Arcadia-IT and PatientCare-IT) and SNOMED v3.5 was respectively
of 19.4% and 32.4%. After expert validation the mapping between
Arcadia-IT and SNOMED v3.5 increased to 86.2% (precision: 84%
and recall: 19%). The mapping between PatientCare-IT and
SNOMED v3.5 increased to 65.3% (precision: 62% and recall: 31%)
(table 1). The use of SNOMED v3.5 as pivot terminology for the
Arcadia-IT-to-PatientCare-IT increased the recall of the algorithm
from 84% to 97%. In conclusion, 13.4% of the data elements of the
eCRFs were linked to data elements of the DxCare library and were
therefore candidate for pre-population.
4.3.2. Exporting clinical research data from EHR to CDMS
During the Arcadia trial execution, the IHE XDM integration
proﬁle was used by DxCare (EHR) (acting as ‘‘Document Source’’)
to send to the CDMS Marvin (XClinical) (acting as Document
Consumer) clinical trial data (ODM ﬁles) of recruited patients. Val-
idation was done in the CDMS, i.e. all data exported to the clinical
care research context was approved by the investigator before it
was persisted in the CDM system (Fig. 3).5. Conclusion
Well-deﬁned, standards-based integration proﬁles can enable
semantic interoperability across many of the traditional barriers
that populate the Translational Medicine Continuum. In particular,
such proﬁles provide support for data collection processes that are
both easy to use and minimally disruptive when integrated into
clinical care activities. The RE-USE project demonstrates how, the
application of a ‘‘semantic mapping and synchronization’’ module
that links data elements in EHR templates to those in eCRFs, the
EHR can be used as a single-entry data source for data that can
then be re-purposed for use in a clinical trial context. Speciﬁcally,
using the EHR/CDMS integration solution of the RE-USE project –
developed and deployed in the clinical care context of the Georges
Pompidou European Hospital (HEGP) and the multi-center, clinical
research context of the Acadia clinical trial – data are entered intoTable 1
Results of the mapping between Arcadia-IT and PatientCare-IT and between the template i
for true positive, TN for true negative, FP for false positive and FN for false negative.
Automatic mapping (%)
(TP + FP/n)
Expert validated mapp
(TP + FN/n)
Arcadia-IT (n = 232)/
PatientCare-IT
15.9 13.4
Arcadia-IT/SNOMED 3.5 19.4 86.2
Hypertension-IT (n = 419)/
SNOMED 3.5
32.4 65.3the EHR system and then submitted to clinical investigators for
approval before being extracted and transferred for persistence
in a CDMS.
The results of the applying the RE-USE platform – including the
semantic synchronization module – in the context of the Arcadia
clinical research study revealed that only 13.4% of required eCRF
data elements could be found in existing EHR templates, a number
that is substantially lower than that previously reported in the lit-
erature discussing EHR/CDMS integration solutions. It is important
to note that this number is a measure of mappable data elements
between the two contexts and does not, a priori, indicate a 86%
disagreement on data semantics between the two contexts. Rather,
there was, in actuality, considerably higher agreement between cli-
nicians and clinical researchers on the meaning of various data ele-
ments collected in the two contexts. The 13.4% ‘‘agreement’’ ﬁgure
is, in fact, a reﬂection of the number of data elements that are di-
rectly mappable between the two ‘‘Model of Use’’ contexts. The
86% number therefore represents both semantic and syntactic
(i.e. representational) disagreements, i.e. it includes equivalent
semantics (to a human being) viewed as different by virtue of
the fact that the data elements are collected – and therefore repre-
sented – through a sequence of different questions, e.g. some of
which have T/F answers vs a single, multi-dimensioned ﬁeld-entry
question.
As noted above, a core component of the RE-USE project is the
‘‘semantic synchronization’’ module, a software component that
utilizes semantic mapping services to identify semantic overlap
between data elements in eCRFs and data elements of patient-care
centric templates of the EHR, thereby enhancing the pre-popula-
tion capabilities. In particular, we demonstrated the use of
SNOMED 3.5 as the pivot reference terminology enhances the re-
call of the mapping services. However, our results also point out
the difﬁcult challenges involved in semantic integration between
the clinical care and clinical research contexts. In order for the syn-
chronization process to become a scalable activity, the current
amount of effort required by clinicians to develop usable mappings
must be reduced. As such, within the context of the EHR4CR pro-
ject, a project recently launched as part of the European Innovative
Medicines Initiative (IMI), we plan to extend the capabilities devel-
oped in the RE-USE project. Speciﬁcally, we plan to develop new
semantic interoperability services that will support post-coordina-
tion capabilities that will, in turn, enable participating sites to en-
hance the automatic detection of the semantic agreement between
data elements in eCRFs and patient care templates available in
EHRs so that these elements can be collected once and mapped
accordingly as described in the RE-USE Methods. In addition, it
should be noted that the synchronization process described above
is not speciﬁcally dedicated to application as described for use in
the RE-USE project. In particular, the synchronization approach
could be applied in the context of other approaches to EHR/CDMS
mapping, as its core capability is simply that of cross-context data
mapping. For example, in the RFD-CRD approach, the synchroniza-
tion process could be used in order to dynamically extend the
scope of CRD in terms of clinical data candidate to be repurposed
for clinical research.nterface terminologies (Arcadia-IT and Hypertension-IT) and SNOMED v3.5. TP stands
ing (%) TP FP FN TN Precision
(TP/TP + FP)
Recall
(TP/TP + FN)
26 11 5 191 70 84
38 7 162 25 84 55
44 27 99 49 62 31
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associated processing capabilities that are required of an EHR. In
particular, the EHR must ﬁrst have the capability to manage a li-
brary of data elements which have been deemed ‘‘common’’ be-
tween the clinical care and clinical research contexts. In the RE-
USE project, this capability was provided by the custom-developed
DxCare module. Secondly, the EHR must provide an internal mech-
anism to pre-populate ﬁelds of a target form with clinical data al-
ready part of the EHR’s persistence layer by virtue of being
captured via different data collection forms. In general, the ability
to integrate data collection templates not directly developed as na-
tive to the EHR system addresses requirements of a larger scope
than the relatively narrow scope of the RE-USE project. For this rea-
son, we believe that adding such capabilities to an EHR system
could provide a clear value proposition for the EHR system’s devel-
opers. For example, in the patient care domain, the ability to share/
exchange data collection forms (e.g. HL7 CDA templates) covering a
number of clinical specialty sub-domains would be extremely use-
ful in allowing hospital A to take advantage of a data capture solu-
tion designed in hospital B. One can therefore imagine that the
combination of the ‘‘Cross Enterprise Template Sharing’’ (XTS) inte-
gration proﬁle with synchronization process described for the RE-
USE project could actually address a broader scope than ‘‘just’’
EHR/CDMS integration, and, as such, could – over time – become
sufﬁciently attractive to EHR vendors to be scalable in the EHR/
CDMS integration context.
Representational differences in semantically isomorphic data
underscore the importance of enterprise-level data element deﬁni-
tion standards and associated governance mechanisms that ensure
that enterprise representation conventions are consistently ap-
plied. At present, no such framework or governance exist at the
Assistance Publique-Hopitaux de Paris (AP-HP). However, such a
framework will clearly be necessary in order for the AP-HP to max-
imally leverage its ever-growing data assets. Moreover, at the pan-
European level – e.g. within the IMI’s EHR4CR project – governance
mechanisms will, of necessity, need to be deﬁned to address the
key challenges of semantic integration of clinical care and clinical
research data. As such, the EHR4CR project will consider several ef-
forts focused on developing standards that will drive the data cap-
ture, representation and communication from the clinical care
context to the clinical research context based on agreed upon clin-
ical data structure deﬁnitions, e.g. HL7 templates or archetypes
standardized in ISO EN13606 Part 2, serialized at communications
time using a standard data types speciﬁcation, e.g. ISO 21090, and
bound – when appropriate – to value sets using terms from appro-
priate reference terminologies, e.g. SNOMED, LOINC, etc., whose
terms are served by terminology servers via CTS2 interfaces [31].
In addition, the EHR4CR project is expected to rely on the layered
and context-aware semantic infrastructure being deﬁned by the
CDISC SHARE project, a cooperative effort whose goal is to build
an open-source, global electronic library of shared semantic struc-
tures for use at the clinical care/clinical trial boundary. SHARE will
be based on the BRIDG model – a model that is, in turn, a subset of
the HL7 Reference Information Model. SHARE is expected to pro-
vide a common language that clinical studies can use to improve
the shared semantic links between biomedical research and clini-
cal care [23]. All of the efforts point to the critical assertion that lies
at the base of the RE-USE project, i.e. data integration across multi-
ple data-collection-and-usage contexts is a critical success factor in
Translational Medical Informatics [32–34].
Like other EHR/CDMS integration solutions, the RE-USE solution
has multiple beneﬁts including: (i) single-time-data-entry econ-
omy of effort (EHR and CDMS users); (ii) reduced errors resulting
from elimination of redundant entry; and (iii) reduced data moni-
toring workload (CDMS users). Although each of these beneﬁts
could arguably be of indirect beneﬁt to patients, the potentialvalue-add of the RE-USE solution to directly improve patient care
is, in our opinion, the most salient beneﬁt of the integrated, sin-
gle-source approach. Collecting clinical research data – including
data required for adverse event monitoring – in EHR, provide valu-
able input into the larger context of ongoing patient diagnosis and
treatment planning.Acknowledgments
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